Altan Pharma Ltd., an Irish specialty pharma company, has acquired The GES Group, a privately held group that develops, manufactures and markets specialty injectable drugs. GES, headquartered in Spain, is comprised of three operating companies: GES Genéricos Españoles Laboratorio, S.A.U.; Genfarma Laboratorio, S.L. and Biomendi, S.A.U. Financial terms were not disclosed.   GES has been providing the Spanish hospital market with a comprehensive line of injectable drugs since 1985. The company is ...